Cargando...
Prostate-Specific Antigen (PSA) Screening and New Biomarkers for Prostate Cancer (PCa)
PSA screening reduces PCa-mortality but the disadvantages overdiagnosis and overtreatment require multivariable risk-prediction tools to select appropriate treatment or active surveillance. This review explains the differences between the two largest screening trials and discusses the drawbacks of s...
Gardado en:
| Publicado en: | EJIFCC |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
The Communications and Publications Division (CPD) of the IFCC
2014
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4975191/ https://ncbi.nlm.nih.gov/pubmed/27683457 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|